Your browser doesn't support javascript.
loading
Selection criteria for early breast cancer patients in the DBCG proton trial - The randomised phase III trial strategy.
Stick, Line Bjerregaard; Lorenzen, Ebbe Laugaard; Yates, Esben Svitzer; Anandadas, Carmel; Andersen, Karen; Aristei, Cynthia; Byrne, Orla; Hol, Sandra; Jensen, Ingelise; Kirby, Anna M; Kirova, Youlia M; Marrazzo, Livia; Matías-Pérez, Angela; Nielsen, Mette Marie Bruun; Nissen, Henrik Dahl; Oliveros, Sileida; Verhoeven, Karolien; Vikström, Johan; Offersen, Birgitte Vrou.
Afiliação
  • Stick LB; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Lorenzen EL; Niels Bohr Institute, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
  • Yates ES; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Anandadas C; Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark.
  • Andersen K; Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark.
  • Aristei C; Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK.
  • Byrne O; Department of Radiotherapy, Herlev & Gentofte Hospital, Herlev, Denmark.
  • Hol S; Department of Medicine and Surgery, Radiation Oncology Section, University of Perugia & Perugia General Hospital, Perugia, Italy.
  • Jensen I; Department of Medical Physics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Kirby AM; Department of Radiation Oncology, Institute Verbeeten, Tilburg, the Netherlands.
  • Kirova YM; Department of Medical Physics, Aalborg University Hospital, Aalborg, Denmark.
  • Marrazzo L; Department of Radiotherapy, The Royal Marsden Hospital NHS Foundation Trust & Institute of Cancer Research, London, UK.
  • Matías-Pérez A; Department of Radiation Oncology, Institut Curie, Paris, France.
  • Nielsen MMB; Department of Medical Physics, Careggi University Hospital, Florence, Italy.
  • Nissen HD; Département de Radiothérapie, Institut Gustave Roussy, Villejuif, France.
  • Oliveros S; Department of Oncology, Zealand University Hospital, Næstved, Denmark.
  • Verhoeven K; Department of Oncology, Vejle Sygehus, Vejle, Denmark.
  • Vikström J; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Offersen BV; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Clin Transl Radiat Oncol ; 27: 126-131, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33659716
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca